November 9, 2015 / 2:37 PM / in 2 years

BUZZ-Valeant Pharmaceuticals International Inc: Business plan update on Tuesday

** Canadian drug maker’s U.S.-listed shares up 3 pct at $84.20

** Valeant said it would hold conference call on Tuesday to give update on its operations and plans to transition from specialty pharmacy, Philidor

** Valeant CEO Michael Pearson has come under increasing pressure as company’s stock plunged from $263.70 on Aug. 5 to below $80 last week on scrutiny over high price markups for its drugs and accusations it used Philidor to inflate revenue

** TAKE A LOOK-Valeant cuts ties with beleaguered pharmacy

** Up to Friday’s close, stock had fallen 66 pct since Sept. 18, a day before Democratic Presidential candidate Hillary Clinton tweeted about pharmaceutical price gouging

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below